Zacks Research Brokers Reduce Earnings Estimates for BIO
Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) – Analysts at Zacks Research decreased their Q3 2025 EPS estimates for Bio-Rad Laboratories in a research note issued on Thursday, March 6th. Zacks Research analyst R. Department now anticipates that the medical research company will post earnings per share of $2.72 for the quarter, down from their […]
Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) – Analysts at Zacks Research decreased their Q3 2025 EPS estimates for Bio-Rad Laboratories in a research note issued on Thursday, March 6th. Zacks Research analyst R. Department now anticipates that the medical research company will post earnings per share of $2.72 for the quarter, down from their […]
